Free Trial

Rep. Tim Moore Purchases Shares of Centene Corporation (NYSE:CNC)

Centene logo with Medical background

Key Points

  • Representative Tim Moore recently purchased between $15,001 and $50,000 in Centene Corporation (NYSE:CNC) stock on July 30th, 2025.
  • Centene's stock has decreased by 2.7%, with a current trading price around $25.20, significantly lower than its fifty-two week high of $80.59.
  • Analysts have downgraded Centene's price targets, with several firms reducing their estimates to a range between $28.00 and $31.00, indicating a shift in market sentiment.
  • Five stocks we like better than Centene.

Representative Tim Moore (R-North Carolina) recently bought shares of Centene Corporation NYSE: CNC. In a filing disclosed on August 05th, the Representative disclosed that they had bought between $15,001 and $50,000 in Centene stock on July 30th.

Representative Tim Moore also recently made the following trade(s):

  • Purchased $15,001 - $50,000 in shares of Krispy Kreme NASDAQ: DNUT on 7/30/2025.
  • Purchased $15,001 - $50,000 in shares of Harley-Davidson NYSE: HOG on 7/30/2025.
  • Purchased $15,001 - $50,000 in shares of Verizon Communications NYSE: VZ on 7/29/2025.
  • Purchased $15,001 - $50,000 in shares of Intel NASDAQ: INTC on 7/29/2025.
  • Purchased $1,001 - $15,000 in shares of Krispy Kreme NASDAQ: DNUT on 7/29/2025.
  • Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/29/2025.
  • Purchased $1,001 - $15,000 in shares of Centene NYSE: CNC on 7/22/2025.
  • Purchased $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 7/21/2025.
  • Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/21/2025.
  • Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/18/2025.

Centene Price Performance

CNC traded up $0.32 during trading on Friday, reaching $25.58. The company's stock had a trading volume of 11,416,944 shares, compared to its average volume of 22,123,356. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.64. The firm has a fifty day simple moving average of $40.30 and a two-hundred day simple moving average of $53.24. Centene Corporation has a 1 year low of $25.08 and a 1 year high of $80.59. The company has a market cap of $12.56 billion, a price-to-earnings ratio of 6.33, a PEG ratio of 1.05 and a beta of 0.40.

Centene (NYSE:CNC - Get Free Report) last announced its quarterly earnings results on Friday, July 25th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.23 by ($0.39). The firm had revenue of $48.74 billion for the quarter, compared to analyst estimates of $44.71 billion. Centene had a return on equity of 9.57% and a net margin of 1.15%. The firm's quarterly revenue was up 22.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.42 EPS. As a group, analysts anticipate that Centene Corporation will post 6.86 EPS for the current year.

Insider Activity at Centene

In related news, Director Theodore R. Samuels II acquired 9,000 shares of the firm's stock in a transaction on Monday, July 28th. The stock was bought at an average price of $27.62 per share, for a total transaction of $248,580.00. Following the completion of the purchase, the director directly owned 32,000 shares of the company's stock, valued at approximately $883,840. The trade was a 39.13% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.36% of the company's stock.

Hedge Funds Weigh In On Centene

Several institutional investors have recently modified their holdings of the business. Pinney & Scofield Inc. acquired a new position in shares of Centene during the fourth quarter worth $25,000. Ameriflex Group Inc. acquired a new position in shares of Centene during the fourth quarter worth $26,000. Quarry LP acquired a new position in shares of Centene during the first quarter worth $26,000. Studio Investment Management LLC acquired a new position in shares of Centene during the fourth quarter worth $32,000. Finally, Golden State Wealth Management LLC grew its stake in shares of Centene by 203.1% during the first quarter. Golden State Wealth Management LLC now owns 579 shares of the company's stock worth $35,000 after purchasing an additional 388 shares in the last quarter. Institutional investors and hedge funds own 93.63% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Morgan Stanley cut their price target on shares of Centene from $33.00 to $28.00 and set an "equal weight" rating for the company in a report on Monday, August 4th. Wall Street Zen downgraded shares of Centene from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Jefferies Financial Group cut their price target on shares of Centene from $64.00 to $61.00 and set a "hold" rating for the company in a report on Tuesday, April 29th. UBS Group cut their price target on shares of Centene from $45.00 to $31.00 and set a "neutral" rating for the company in a report on Monday, July 28th. Finally, Truist Financial cut their target price on Centene from $42.00 to $35.00 and set a "buy" rating on the stock in a research report on Monday, July 28th. One analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, Centene has a consensus rating of "Hold" and an average price target of $42.20.

Check Out Our Latest Stock Report on CNC

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina's 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Moore (Republican Party) ran for election to the U.S. House to represent North Carolina's 14th Congressional District. He won in the general election on November 5, 2024. Moore served as speaker of the House from 2015 to 2025. Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

About Centene

(Get Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Featured Stories

Should You Invest $1,000 in Centene Right Now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.